Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ei Yamada"'
Autor:
Yoshimi Saito, Ei Yamada, Ryuichi Morishita, Akihiko Murakami, Chieka Sasakura, Tadashi Mikami, Takao Komatsuno, Yuichi Daikyoji, Naoya Sato, Tetsuya Ishihama, Kazuo Suzuki, Hiromi Rakugi, Hiroki Hayashi, Hironori Nakagami
Publikováno v:
Translational and Regulatory Sciences. 3:115-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64db88961f3f4a6660674dc43eeba8fb
https://doi.org/10.33611/trs.2021-016
https://doi.org/10.33611/trs.2021-016
Autor:
Ryuichi Morishita, Ei Yamada, Hironori Nakagami, Chieka Sasakura, Yuichi Daikyoji, Tetsuya Ishihama
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 45(1)
We have been developing an angiotensin II vaccine for hypertension. We conducted a placebo-controlled dose escalation study to investigate the safety, tolerability, and immunological responses of this angiotensin II vaccine (AGMG0201). AGMG0201 was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f72b659741c442505da1d9a260eeee6
https://pubmed.ncbi.nlm.nih.gov/34707217
https://pubmed.ncbi.nlm.nih.gov/34707217
Autor:
Ei Yamada, Yasushi Takeya, Ryuichi Morishita, Tetsuya Ishihama, Hiromi Rakugi, Mitsuaki Chujo, Munehisa Shimamura, Hironori Nakagami
Publikováno v:
Current gene therapy. 20(1)
Objectives: The objective of this combined analysis of data from clinical trials in Japan, using naked plasmid DNA encoding hepatocyte growth factor (HGF), was to document the safety and efficacy of intramuscular HGF gene therapy in patients with cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5bc30bdcb37b63b7792e8e0dfb9874
https://pubmed.ncbi.nlm.nih.gov/32416690
https://pubmed.ncbi.nlm.nih.gov/32416690
Autor:
Mika Ohyama, Toshinori Ide, Mariko Nakano, Akihiro Iwamatsu, Kazuo Kobayashi, Yukiko Shimada, Yasutaka Kakiuchi, Ei Yamada, Naoko Yano, Narie Sasaki-Higashiyama, Kazuhiko Kaji, Kimiko Murakami-Murofushi, Fumi Ikeda, Hiromu Murofushi, Sohsuke Ichikawa, Kiyoto Nishiyama, Yasuko Ogiwara
Publikováno v:
Biochemical and Biophysical Research Communications. 388:328-332
A novel telomerase-associated protein was isolated from porcine testis. The 115-kDa protein, purified with telomerase activity, was molecular cloned using human cDNA library, and identified as MOV10. The expression levels of both MOV10 mRNA and MOV10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24eb6abd8e077cbad975e53674d328e2
https://doi.org/10.1016/j.bbrc.2009.08.002
https://doi.org/10.1016/j.bbrc.2009.08.002
Autor:
Yoshikazu Honda, Yoshiko Yoshiyama, Toshiro Maeda, Yohko K. Shimizu, Yasushi Ono, Ei Yamada, Toshio Shikata, Jun Kondo
Publikováno v:
Journal of General Virology. 71:1999-2004
Blood-borne type non-A, non-B (NANB) hepatitis-associated microtubular aggregates protein was isolated and partially sequenced. The microtubular aggregates were isolated from the hepatocytes of NANB-infected chimpanzees and were found to have a buoya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191f0fb2c49c51910c8eeafe836a1416
https://doi.org/10.1099/0022-1317-71-9-1999
https://doi.org/10.1099/0022-1317-71-9-1999
Autor:
Yoshiharu Matsuura, Makoto Seki, Tatsuo Miyamura, Wang Ling, Michihiro Iwashiro, Kyoko Higo, Toru Masuda, Akinori Ishimoto, Minoru Okuma, Yoshikazu Honda, Yoshinao Kubo, Kazuhiro Kakimi, Kagemasa Kuribayashi, Masahiko Sakai, Hirohiko Kobayashi, Ei Yamada
Publikováno v:
The Journal of general virology. 76
In this study, we characterized the B cell and T cell responses to the hydrophilic portion of hepatitis C virus (HCV) core protein in two strains of mice and identified the respective antigen determinants. BALB/c (H-2d) and C57BL/6 (B6:H-2b) mice wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03635783f75a79c12d2b3e6a131e8af3
https://pubmed.ncbi.nlm.nih.gov/7537326
https://pubmed.ncbi.nlm.nih.gov/7537326
Autor:
Kunihiko Ohta, Jun Kondo, Kaoru Fukuda, Jiro Sugimoto, Ei Yamada, Yoshikazu Honda, Makoto Seki
Publikováno v:
Journal of biotechnology. 38(3)
The amino-terminal half of putative nucleocapsid (core) protein (amino acids 1-115) of hepatitis C virus (HCV) was directly overproduced in Escherichia coli under the control of the tac promoter. Overproduction of core antigen was achieved by inserti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5407acedc28520389adb747aec7d1a
https://pubmed.ncbi.nlm.nih.gov/7765873
https://pubmed.ncbi.nlm.nih.gov/7765873
Autor:
Jun Kondo, Ei Yamada, Tatsurou Shibui, Yoshiko Yoshiyama, Kazuhiro Takahashi, Shigetada Nakanishi, Yohko K. Shimizu, Toshiro Maeda, Yutaka Teranishi, Yoshikazu Honda, Michiru Kamizono, Rie Matsui, Naomi Kitamura
Publikováno v:
The Journal of general virology. 71
A 1.7 kb cDNA encoding a novel antigen (p44; apparent M r 44K) associated with non-A, non-B (NANB) hepatitis, was isolated from the hepatic cDNA library of a chimpanzee infected with NANB hepatitis. The library was screened with a monoclonal antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95906751f653dd8d1cac92a907c19967
https://pubmed.ncbi.nlm.nih.gov/2170570
https://pubmed.ncbi.nlm.nih.gov/2170570
Autor:
Nakao Ishida, Atsushi Kanno, Shiroh Onodera, Yasuyuki Abe, Yasuko Nagatsuka, Hitoshi Ohori, Akira Tateda, Ei Yamada, Takao Togoh
Publikováno v:
Journal of Medical Virology. 12:161-178
The antigen/antibody systems specific for non-A, non-B hepatitis (NANB) were studied using urine samples as the antigen source and sera for the antibody source. Two immunologically distinct systems, SO-antigen/anti-SO and MI-antigen/anti-MI were disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df4693a4f4d555070d274355410c371d
https://doi.org/10.1002/jmv.1890120302
https://doi.org/10.1002/jmv.1890120302
Publikováno v:
Journal of General Virology. 65:405-414
A polypeptide of 21 500 mol. wt., structurally associated with hepatitis B virus core particles, was shown to have two kinds of HBeAg antigenicity (HBeAg/1 and HBeAg/2). This was revealed by transferring a single core peptide from polyacrylamide gels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d796669e2666c8317d2f909953f3a0
https://doi.org/10.1099/0022-1317-65-2-405
https://doi.org/10.1099/0022-1317-65-2-405